AI News
DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI
Google-backed startup eyes the next frontier of drug discovery using advanced generative AI models.
Read the full story at Bloomberg TechnologyBT
Bloomberg Technology
Source
Bloomberg Technology
AI Analysis
Generated insight by OnAirToday AI
Isomorphic Labs is leveraging Google DeepMind's advanced protein-folding architecture to fundamentally shorten the time required for pharmaceutical drug discovery. By shifting from traditional trial-and-error laboratory methods to predictive computational modeling, this initiative represents a major leap in AI-driven precision medicine.
Powered by AI • Not a substitute for human analysisMore Insights →
Share
Filed under:AI News
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.